May 23: Difference between revisions
Jump to navigation
Jump to search
FEisenberg (talk | contribs) No edit summary |
FEisenberg (talk | contribs) |
||
| Line 1: | Line 1: | ||
== May 23 QRPH Face-to-Face Meeting Minutes == | == May 23 QRPH Face-to-Face Meeting Minutes == | ||
Attendees: | Attendees: | ||
Floyd Eisenberg (Siemens) | * Floyd Eisenberg (Siemens) | ||
Jason Colquit (Greenway Medical Systems) | * Jason Colquit (Greenway Medical Systems) | ||
Sheila Teasdale (AMA) | * Sheila Teasdale (AMA) | ||
Delane Heldt (AMA) | * Delane Heldt (AMA) | ||
Harry Solomon (GE) | * Harry Solomon (GE) | ||
Patty Craig (Joint Commission) | * Patty Craig (Joint Commission) | ||
Jan Orton (Intermountain Healthcare) | * Jan Orton (Intermountain Healthcare) | ||
Randolph Barrows (MedAllies) | * Randolph Barrows (MedAllies) | ||
Daemon Whittenberg (Greenway Medical Systems) | * Daemon Whittenberg (Greenway Medical Systems) | ||
Joann Larson (Kaiser) | * Joann Larson (Kaiser) | ||
Ana Estelrich (GMP-DIP) | * Ana Estelrich (GMP-DIP) | ||
Chris Carr (RSNA) | * Chris Carr (RSNA) | ||
# Clinical Research Profile | # Clinical Research Profile | ||
Revision as of 12:07, 23 May 2008
May 23 QRPH Face-to-Face Meeting Minutes
Attendees:
- Floyd Eisenberg (Siemens)
- Jason Colquit (Greenway Medical Systems)
- Sheila Teasdale (AMA)
- Delane Heldt (AMA)
- Harry Solomon (GE)
- Patty Craig (Joint Commission)
- Jan Orton (Intermountain Healthcare)
- Randolph Barrows (MedAllies)
- Daemon Whittenberg (Greenway Medical Systems)
- Joann Larson (Kaiser)
- Ana Estelrich (GMP-DIP)
- Chris Carr (RSNA)
- Clinical Research Profile
- “Other option” requires review – Send to QRPH TC – Schedule one call
- Drug Safety Profile
- Pull content from Clinical Research Profile
- E2B describes data elements
- How to describe what was the adverse event
- Need to identify the information to be send and how based on the trigger
- Calls
- At risk June 9
- White paper
- Requires 2 calls